Expert Interview
A Discussion With The Acting Chair of the FDA's Vaccines and Related Biological Products Advisory Comm on the potential flu vaccine utilizing mRNA technology to protect against many subtypes of the Influenza Virus
Ticker(s): IBBInstitution: University of Michigan
- Acting Chair of the FDA's Vaccines and Related Biological Products Advisory Committee.
- Emeritus Professor, Epidemiology & Professor, Global Public Health at University of Michigan.
- Primary current concerns include occurrence, etiology and prevention of infectious diseases in industrialized and developing countries; frequency and cause of respiratory infections in families living in the community, and in factors which predict the occurrence and prevention of these illnesses; research and training to respond to bioterrorist threats.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
